Advances in research of stem cell therapy for ischemic myocardial disease

doi:10.3877/cma.j.issn.1674-0785.2019.01.014

Abstract

Abstract:

Ischemic myocardial disease is one of the major diseases affecting human health. Stem cell transplantation for treatment of ischemic myocardial diseases has become a hot research topic in recent years. Transplantation of stem cells can promote angiogenesis and heart tissue regeneration, reduce scarred area, and improve heart systolic function. However, results from clinical studies on stem cell therapy for ischemic myocardial disease are inconsistent, which could result from the source of stem cells, infusion ways, injection dosage, and follow-up time. Additionally, stem cell transplantation is associated with immune rejection, tumor formation, and other potential safety issues. The main objective of this review is to discuss the influencing factors and safety problems in stem cell therapy for ischemic myocardial disease.

Key words: Ischemic myocardial disease, Cardiac repair, Stem cell transplantation, Mesenchymal stem cell

Yusen Zhang, Guanghui Cui, Li Liu, Xiaodong Yang, Ziqian Zhou, Weiwei Zhang, Yun Chen. Advances in research of stem cell therapy for ischemic myocardial disease[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(01): 65-68.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2019.01.014

https://zhlcyszz.cma-cmc.com.cn/EN/Y2019/V13/I01/65

References 32

1	Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association [J]. Circulation, 2016, 133(4): e38-360.
2	Williams AR, Hatzistergos KE, Addicott B, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction [J]. Circulation, 2013, 127(2): 213-223.
3	Tang YL, Wang YJ, Chen LJ, et al. Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications [J]. Exp Biol Med (Maywood), 2013, 238(3): 294-300.
4	Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions[J]. Circ Res, 2013, 113(6): 810-834.
5	Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis [J]. Arch Intern Med, 2007, 167(10): 989-997.
6	Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts [J]. Science, 1998, 282(5391): 1145-1147.
7	李松，苗增民，高佩安, 等. 胚胎干细胞技术[J]. 生物学通报, 2006, 41(7): 15-16.
8	Baldwin T. Morality and human embryo research. Introduction to the Talking Point on morality and human embryo research [J]. EMBO Rep, 2009, 10(4): 299-300.
9	张学峰，张美荣，胡建霞, 等. 异种脐带间充质干细胞静脉应用的安全性[J]. 中国组织工程研究与临床康复, 2010, 14(32): 5971-5975.
10	Leistner DM, Fischer-Rasokat U, Honold J, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy [J]. Clin Res Cardiol, 2011, 100(10): 925-934.
11	Musialek P, Mazurek A, Jarocha D, et al. Myocardial regeneration strategy using Wharton′s jelly mesenchymal stem cells as an off-the-shelf ′unlimited′therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study[J].Postepy Kardiol Interwencyjnej, 2015, 11(2): 100-107.
12	Aguilera V, Briceño L, Contreras H, et al.Endothelium trans differentiated from Wharton′s jelly mesenchymal cells promote tissue regeneration: potential role of soluble pro-angiogenic factors [J]. PLoS One, 2014, 9(11): e111025.
13	Gao LR, Chen Y, Zhang NK, et al. Intracoronary infusion of Wharton′s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial [J]. BMC Med, 2015, 13: 162.
14	Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells [J]. Mol Biol Cell, 2002, 13(12): 4279-4295.
15	Henry TD, Pepine CJ, Lambert CR, et al. The Athena trials: autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction [J]. Catheter Cardiovasc Interv, 2017, 89(2): 169-177.
16	Terrovitis J, Lautamäki R, Bonios M, et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery [J]. J Am Coll Cardiol, 2009, 54(17): 1619-1626.
17	Blocklet D, Toungouz M, Berkenboom G, et al. Myocardial homing of nonmobilized peripheral-blood CD34^＋ cells after intracoronary injection [J]. Stem Cells, 2006, 24(2): 333-336.
18	Hou D, Youssef EA, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials [J]. Circulation, 2005, 112(9 Suppl): I150-156.
19	Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts [J]. Nat Med, 2003, 9(9): 1195-1201.
20	Heeger CH, Jaquet K, Thiele H, et al. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial [J]. EuroIntervention, 2012, 8(6): 732-742.
21	Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction [J]. Eur Heart J, 2006, 27(9): 1114-1122.
22	Gyöngyösi M, Wojakowski W, Lemarchand P, et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data [J]. Circ Res, 2015, 116(8): 1346-1360.
23	Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis [J]. Eur Heart J, 2014, 35(15): 989-998.
24	Fisher SA, Doree C, Mathur A, et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure [J]. Cochrane Database Syst Rev, 2016, 12: CD007888.
25	Tian T, Chen B, Xiao Y, et al. Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials [J]. Atherosclerosis, 2014, 233(2): 485-492.
26	Lee SH, Hong JH, Cho KH, et al. Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis [J]. Stem Cell Res Ther, 2016, 7(1): 153.
27	Fisher SA, Doree C, Mathur A, et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure [J]. Cochrane Database Syst Rev, 2016, 12: CD007888.
28	Traverse JH, Henry TD, Pepine CJ, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial [J]. JAMA, 2012, 308(22): 2380-2389.
29	Wang Z, Wang L, Su X, et al. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials [J]. Stem Cell Res Ther, 2017, 8(1): 21.
30	Malliaras K, Li TS, Luthringer D, et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells [J]. Circulation, 2012, 125(1): 100-112.
31	Florea V, Rieger AC, DiFede DL, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study) [J]. Circ Res, 2017, 121(11): 1279-1290.
32	Suncion VY, Ghersin E, Fishman JE, et al. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: an analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial [J]. Circ Res, 2014, 114(8): 1292-1301.

[1]	Yangwenxiang Wei, Haoran Huang, Yuhao Liu, Zhenqiu Chen, Haibin Wang, Chi Zhou. Outlooks and challenges in cell therapy of osteonecrosis of femoral head [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 694-700.
[2]	Zhuoyi Fu, Shengcheng Tang, Qiaomei Bu, Gaobing Xu, Anping Wu, Wei Cai, Ming Yang, Haitao Tan. Research progress of magnesium in treatment of osteoarthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(03): 354-362.
[3]	Zong Shen, Chenru Wei, Banghui Zhu, Yulu Bao, Guosheng Wu, Yu Sun. Advances in animal experiment studies on mesenchymal stem cells for the treatment of inhalation injury [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(02): 180-183.
[4]	Xin Kong, Baoquan Song, Yin Liu, Jian Zhang, Huiying Qiu, Depei Wu. Intractable hiccup induced by allogeneic hematopoietic stem cell transplantation: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 253-255.
[5]	Yingjun Tang, Huajuan Li, Saini Wang, Wang Xu, Feng Liu, Xi Li, Xinbao Hao, Huaping Huang. Effect and mechanism of human umbilical cord mesenchymal stem cells (HU-MSCs) transplantation on emphysema mice [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(04): 476-480.
[6]	Ye Li, Jie He, Jinxiu Hu, Jinxiang Wang, Chuan Tian, Hang Pan, Mengdie Chen, Xiaojuan Zhao, Li Ye, Min Zhang, Xinghua Pan. Highly active mesenchymal stem cells interfere with ovarian aging in macaques [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 210-219.
[7]	Huiling Long, Mi Lin, Ting Shao. Research progress and application of three-dimensional spherical mesenchymal stem cell culture technology [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 229-234.
[8]	Wenhui Liu, Tao Wu, Xi Zhang. Advances in mesenchymal stem cells combined with thrombopoietin receptor agonists in platelet recovery after allogeneic hematopoietic stem cell transplantation [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 242-246.
[9]	Hongmin Wang, Yunbo Xie, Yanhu Wang, Fusheng Wang. The advance of clinical research in mesenchymal stem cell treatment for COVID-19 [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 247-256.
[10]	Fuhao Qin, Zheng Zheng, Bin Jiang. Research progress of mesenchymal stem cells in the treatment of perianal fifistulizing Crohn's disease [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(03): 172-177.
[11]	Jiuli Yuan, Dan Liu, Linli Li, Jinyu Liu. Basic research and clinical application of hair follicle-derived mesenchymal stem cells [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(03): 189-192.
[12]	Yuting Chen, Ying Zhou, Yafei Lu, Bin Jiang. Advances in the function and mechanism of hypoxic preconditioned mesenchymal stem cells [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(02): 115-120.
[13]	Xing Feng, Hongtao Jin, Jun Ma, Yongzhou Song, Aijing Liu. Progress in the treatment of inflammatory arthritis with mesenchymal stem cells [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(02): 87-92.
[14]	Yunzhao Yang, Cheng Zhou, Meihan Shi, Jing Zhao, Xueyuan Bai. Therapeutic effect of human amniotic fluid-derived mesenchymal stem cells on membranous nephropathy in rats [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(04): 181-186.
[15]	Yanqi Song, Xuejing Ren, Wenjuan Wang, Qiuxia Han, Yue Xu, Kaiting Zhuang, Tuo Xiao, Guangyan Cai. Effect of mesenchymal stem cells on ferroptosis in cisplatin-induced acute kidney injury of mice [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(04): 187-193.

Please choose a citation manager

Content to export